Dysfunctional T regulatory cells in multiple myeloma. - Wikidata - awgldk - TriplyDB

Dysfunctional T regulatory cells in multiple myeloma.

Dysfunctional T regulatory cells in multiple myeloma.

http://www.wikidata.org/entity/Q41877240

about

Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma Immunotherapy strategies for multiple myeloma: the present and the future Clinical Impact of the Immunome in Lymphoid Malignancies: The Role of Myeloid-Derived Suppressor Cells Functional interaction of plasmacytoid dendritic cells with multiple myeloma cells: a therapeutic target.The role of regulatory T cells in cancer.New strategies in the treatment of multiple myeloma.Common single nucleotide polymorphisms in immunoregulatory genes and multiple myeloma risk among women in Connecticut.Plasma cell disorders in HIV-infected patients: epidemiology and molecular mechanisms.Tumour cell generation of inducible regulatory T-cells in multiple myeloma is contact-dependent and antigen-presenting cell-independent.FOXP3 and CTLA4 overexpression in multiple myeloma bone marrow as a sign of accumulation of CD4(+) T regulatory cells.Increased T regulatory cells are associated with adverse clinical features and predict progression in multiple myeloma.Tregs and rethinking cancer immunotherapy.Characterization of the Toll-like receptor expression profile in human multiple myeloma cells.Comparative approach to define increased regulatory T cells in different cancer subtypes by combined assessment of CD127 and FOXP3.Immune derangements in patients with myelofibrosis: the role of Treg, Th17, and sIL2Rα.Survivin-specific CD4+ T cells are decreased in patients with survivin-positive myeloma.The cellular immune system in myelomagenesis: NK cells and T cells in the development of myeloma [corrected] and their uses in immunotherapies.The frequency of T regulatory cells modulates the survival of multiple myeloma patients: detailed characterisation of immune status in multiple myeloma.Immunotherapy using dendritic cells against multiple myeloma: how to improve?Cellular immunotherapy using dendritic cells against multiple myeloma Elevated Th22 as well as Th17 cells associated with therapeutic outcome and clinical stage are potential targets in patients with multiple myeloma.MHC class I chain-related protein A antibodies and shedding are associated with the progression of multiple myeloma.Dissecting the multiple myeloma-bone microenvironment reveals new therapeutic opportunities Analysis of the immune system of multiple myeloma patients achieving long-term disease control by multidimensional flow cytometry.Postoperative Regulatory T-Cells and Natural Killer Cells in Stage I Nonsmall Cell Lung Cancer Underwent Video-assisted Thoracoscopic Lobectomy or Thoracotomy Indoleamine 2,3-dioxygenase 1 (IDO1) activity correlates with immune system abnormalities in multiple myeloma.Myeloid-derived suppressor cells regulate growth of multiple myeloma by inhibiting T cells in bone marrow.Tumor-promoting immune-suppressive myeloid-derived suppressor cells in the multiple myeloma microenvironment in humans Lenalidomide-induced immunomodulation in multiple myeloma: impact on vaccines and antitumor responses.Cellular mechanisms of multiple myeloma bone disease Immune therapies.Lack of suppressive CD4+CD25+FOXP3+ T cells in advanced stages of primary cutaneous T-cell lymphoma.Circulating Regulatory T-Cells in Monoclonal Gammopathies of Uncertain Significance and Multiple Myeloma: In Search of a Role.Attenuation of CD8(+) T-cell function by CD4(+)CD25(+) regulatory T cells in B-cell non-Hodgkin's lymphoma.Th17 and Treg cells in bone related diseases.T cells in multiple myeloma display features of exhaustion and senescence at the tumor site.Myeloma cell line-derived, pooled heat shock proteins as a universal vaccine for immunotherapy of multiple myeloma.Drug-mediated and cellular immunotherapy in multiple myeloma.Histone deacetylase inhibitors: potential targets responsible for their anti-cancer effect.The bone marrow stroma in hematological neoplasms--a guilty bystander.

P2860

Q24605861-02343A76-0A42-46B7-A513-7586E93A90D1 Q27021939-E3661546-71AF-4C68-A716-1C6C5E4F729E Q28083973-DEEFE680-BA58-434B-8BD1-6DE809ACA525 Q30490975-CA3D48D3-6CA5-472D-BF78-5C0523A69B20 Q33631986-7C07BAB2-B7AB-4E48-81CB-5D46E30FD87B Q33958520-2817E20C-1B0C-42DC-8F69-3D2B0799DA4A Q34020753-68DA4CDD-46AD-4229-96B4-80F2566D951F Q34256144-01501596-0A24-4FA8-BD74-8566181F85DF Q34292398-0DF5108A-6359-4AA4-827B-6C44242EC35F Q34402407-FDBB193D-0C88-49C0-90BB-336F473A64F6 Q34447864-9030ED90-0EBE-4562-9E7A-37A7442F1043 Q34625147-67C8E052-1B1C-4EA9-9646-B8FE3709A8BC Q34673706-505BB402-FEBD-454D-8D0E-FC4CB49B1F78 Q35195777-9AA7BDC6-9497-4F9D-96B4-49F0E8C40ABA Q35203067-9FCE6D61-271D-45E5-8AB9-618824BA0789 Q35623772-C9BDF6D7-F90F-4B7A-BA20-8E02B453D50D Q35669068-7B8A4907-87F6-4A27-8D50-48D24FCB234D Q35739463-6E0A0DE4-4CCD-4422-9B45-D11E72FF4A94 Q35852574-9C36B5E2-8AFC-475D-B0EB-00E82B8E5004 Q35865581-3CD6CB76-D8DF-4A60-BC58-DAD31C41F108 Q36228476-728CB846-2B0A-4DFC-A77A-BC9BA2B012C4 Q36446189-895CAAD3-50EF-4DB9-B5F3-CEB7DD1A710E Q36447553-2178FB07-514E-4BB8-BC95-16542818C84F Q36498366-99BDC85C-495F-42B0-9A55-4C88B14F4238 Q36523315-561B1486-3488-446B-84FE-1F1E312D4EB1 Q36526999-17A3D3E4-DC85-4954-897A-AF2CE0E5CEFC Q36718300-8BD00B0E-0E99-49BF-AB50-33C8E95573D4 Q36761567-3F0C56F0-688E-4B73-959F-32AFB1953A0E Q36806619-4CCA3F96-D40F-4B43-9419-5047FA2B1F1A Q36925346-C2616C1D-FCD2-432B-884E-06000B5D790A Q36998232-6DBE3471-8C56-4721-AC3B-A3F31DE6C326 Q37052602-12FB6B11-5A8A-4C4C-96F0-D74479FFBA73 Q37132264-FA52B83C-545A-4E59-8564-D91AA007DFA2 Q37188161-E089CA60-B7C3-412C-B632-D2139277B621 Q37239790-411A8521-E956-4E5A-8394-1C799040FAFA Q37390723-96968F38-CE3E-4764-A847-51DF93980F9E Q37412334-F511E7D4-A706-4F44-8F36-7EA9B8C0E530 Q37773257-ED0DC37A-8E5A-4539-B8C6-2E8F653E86F8 Q37821337-62E27699-7C68-444B-9D00-83420CDD519B Q37859253-75CE82F3-69A3-4870-ABCC-D6D826093374

P2860

Dysfunctional T regulatory cells in multiple myeloma.

http://www.wikidata.org/entity/Q41877240

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Dysfunctional T regulatory cells in multiple myeloma.

@en

type

label

Dysfunctional T regulatory cells in multiple myeloma.

@en

prefLabel

Dysfunctional T regulatory cells in multiple myeloma.

@en

P1433

Q41877240-D5E781AB-04CD-47DB-8B52-9A92A733FED7

P1476

Q41877240-08278F56-4720-41FB-9C46-B58B4B6E423C

P2093

Q41877240-1B5A0585-B5D8-4FBC-A6AD-694D3B578644

Q41877240-1E5E1FE8-AB79-4126-B4B6-CF2EDB46C16F

Q41877240-26B00602-05BA-43B7-81A6-BDB4D076DAC7

Q41877240-40380014-BB01-4613-85D4-ED4649A14319

Q41877240-531265DA-9405-4222-BC48-CDE86C6ABD7E

Q41877240-5DE69EB7-88D8-4905-8D0B-268DA53C264E

Q41877240-7F6AC4FB-0D65-4DD6-99F9-34C4AEEFDEE3

Q41877240-8A2CBF65-62CF-4B8C-908C-47506D535355

Q41877240-9B51CCE2-ACC7-4713-9392-47785DED1089

Q41877240-D172FD92-CE12-4FB5-87CF-A3CF683E85EF

P2860

Q41877240-0261B861-720B-4570-86B1-A02667800BC3

Q41877240-10B96B07-1202-46B5-B894-15C3BB05ED5B

Q41877240-14952817-309C-47B2-BBE9-262D6818C848

Q41877240-28AA0F93-F6C2-49C8-9F05-EA8318BEB18B

Q41877240-2CA14C67-3D9B-48B9-98EA-B744513948AC

Q41877240-4B12AF12-595A-4587-8EAE-816851E0965D

Q41877240-50E06860-1263-4794-899E-DC8644D07A97

Q41877240-54971EF9-E814-4C7E-8567-E3561C697ABB

Q41877240-5B138CFD-3148-4EF9-9728-740FCC734DCD

Q41877240-6A6FEFB5-5A42-4719-8EB7-1CC2B33881AB

P304

Q41877240-54AFAF00-2F47-45AF-B83B-B5F3E1DF08FB

P31

Q41877240-80C5FC8D-8F1B-4F09-ABAF-0A01DCDA3EFE

P356

Q41877240-E91B9A03-9765-45CB-8267-5A9AB8A36AAF

P407

Q41877240-204F19C9-3C51-410A-9E3D-AE87E1D50DD3

P433

Q41877240-C35E961B-832D-40A8-B102-9EDF0F54C7F8

P478

Q41877240-FFAF57D0-528B-4854-A429-B43E93807D88

P50

Q41877240-17EDDA76-FDC9-4DA7-B9B1-7E6209F28C85

P577

Q41877240-30EC8210-2BEA-4A07-8DDD-4C456B119F4B

P5875

Q41877240-AED94771-8552-43A6-A29F-236D1E3F180E

P698

Q41877240-A74E8BAB-0FBA-48B5-B357-97BF3F4FDAFF

P932

Q41877240-2EFE7B4B-B89A-4F42-B960-86E25DB99C5A

P356

BLOOD-2005-08-3101

P1433

P1476

Dysfunctional T regulatory cells in multiple myeloma.

@en

P2093

Charles K Allam

http://www.w3.org/2001/XMLSchema#string

Dharminder Chauhan

http://www.w3.org/2001/XMLSchema#string

Elizabeth Blanchard

http://www.w3.org/2001/XMLSchema#string

Hemant S Thatte

http://www.w3.org/2001/XMLSchema#string

John F Daley

http://www.w3.org/2001/XMLSchema#string

Jooeun E Bae

http://www.w3.org/2001/XMLSchema#string

Masood A Shammas

http://www.w3.org/2001/XMLSchema#string

Nikhil C Munshi

http://www.w3.org/2001/XMLSchema#string

Paola Neri

http://www.w3.org/2001/XMLSchema#string

Pierfrancesco Tassone

http://www.w3.org/2001/XMLSchema#string

P2860

Control of regulatory T cell development by the transcription factor Foxp3

Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self

Dendritic cells from patients with myeloma are numerically normal but functionally defective as they fail to up-regulate CD80 (B7-1) expression after huCD40LT stimulation because of inhibition by transforming growth factor-beta1 and interleukin-10.

The IL-6R alpha chain controls lung CD4+CD25+ Treg development and function during allergic airway inflammation in vivo.

Regulatory T cells in autoimmmunity*.

Increase of regulatory T cells in the peripheral blood of cancer patients.

Natural versus adaptive regulatory T cells.

Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists.

Advances in biology of multiple myeloma: clinical applications.

Targeting multiple myeloma cells and their bone marrow microenvironment.

P304

301-304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2005-08-3101

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

107

http://www.w3.org/2001/XMLSchema#string

P50

Kenneth C Anderson

P577

2005-09-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7611055

http://www.w3.org/2001/XMLSchema#string

P698

16150935

http://www.w3.org/2001/XMLSchema#string

P932

1895365

http://www.w3.org/2001/XMLSchema#string